Anna Estival

Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

Lorenzo D’Ambrosio, Nathan Touati, Jean‐Yves Blay et al. · Cancer · 2020 · 134 citations · Full text

A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01)

Carmen Balañá, María Ángeles Vaz Salgado, Juan Manuel Sepúlveda-Sánchez et al. · Neuro-Oncology · 2020 · 103 citations · Full text

Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05)

Ernest Nadal, Delvys Rodríguez‐Abreu, Marta Simó et al. · Journal of Clinical Oncology · 2023 · 93 citations · Full text

SEOM clinical guideline on unknown primary cancer (2017)

Ferrán Losa, G. Soler, Antonio Casado et al. · Clinical & Translational Oncology · 2017 · 69 citations · Full text

Pseudoprogression as an adverse event of glioblastoma therapy

Carmen Balañá, Jaume Capellades, Estela Pineda et al. · Cancer Medicine · 2017 · 58 citations · Full text